Dosulepin

Grey

Brand Name(s):

Indication:Depressive illness, particulary where sedation is required

Rationale:1

Considered:Mar-14

Review Date:Jun-23

Comments:
Updated CG90 Depression in adults: recognition and management
April 18
…………………………
Update to CG9O(Oct2009) Apr16
…………………………
MHRA DRUG SAFETY UPDATE Dec 2007
Dosulepin: measures to reduce risk of fatal overdose, information at: http://www.mhra.gov.uk/Safetyinformation/DrugSafetyUpdate/CON084687

Patients who are currently receiving prescriptions for Dosulepin may continue to receive treatment provided the Prescriber is content that ongoing use is safe and appropriate.
Dosulepin is not recommended to be initiated in new patients.

APC March 2014